| http://www.w3.org/ns/prov#value | - Data and Safety Monitoring Plan: Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity, and dose-finding studies (phase I); efficacy studies (Phase II) and efficacy, effectiveness, and comparative trials (Phase III).
|
